evolcSign inStart free
Menu

Tribune Therapeutics

Preclinical biopharma developing anti-fibrotic medicines that target CCN signaling, for patients with fibrotic disease

Oslo, NorwayFounded 2021tribunetx.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-29

About Tribune Therapeutics

Tribune Therapeutics develops novel medicines to treat fibrosis regardless of its cause or the affected tissue. Its strategy interrupts signaling by CCN protein family members, such as CCN2 (CTGF), that drive the pro-fibrotic pathway. Its most advanced candidate, TRX-44, interferes with activated pro-fibrotic CCN domains. The company reports anti-fibrotic effects in animal models of lung and kidney fibrosis.

The company is a preclinical biopharmaceutical company. Its pipeline is based on research by co-founder Dr. Ole Kaasbøll, built on CCN signaling research in the laboratory of Dr. Håvard Attramadal. The target patients are people with fibrotic diseases that can lead to failure of organs such as the heart, kidneys, lungs or liver.

Tribune Therapeutics is headquartered in Oslo, Norway, and was founded in 2021. It is funded by HealthCap and Novo Seeds. Its leadership includes CEO Georg Vo Beiske, CSO Ole J. Kaasbøll and CTO Berthold Bödeker.

Product: Preclinical anti-fibrotic drug candidates; lead candidate TRX-44 targets pro-fibrotic CCN signaling.

Jobs at Tribune Therapeutics

No open positions listed right now.

More biotech & pharma companies

  • Vitas

    Contract analytical lab in Oslo running DBS biomarker analysis and GMP pharma quality testing for drug, food and research clients
    Oslo, NorwayBiotech & pharmaFounded 19941 open job
    New on Evolc

  • Zelluna

    Clinical-stage biotech developing TCR-guided NK cell therapies for solid cancers, led by ZI-MA4-1 in a Phase 1 trial
    Oslo, NorwayBiotech & pharmaFounded 2011
    New on Evolc

  • Zenit Science

    Life science research and contract services for drug developers and researchers working on serious diseases
    Trondheim, NorwayBiotech & pharmaFounded 2023
    Young companyNew on Evolc

  • Age Labs

    Biomarker discovery and epigenetic analysis for pharmaceutical, nutraceutical and clinical research customers
    Oslo, NorwayBiotech & pharmaFounded 2017
    New on Evolc

  • Agilera Pharma

    Radiopharmaceutical CDMO in Norway, handling development to commercial supply for drug developers and research groups
    Kjeller, NorwayBiotech & pharmaFounded 20211 open job
    Young companyNew on Evolc

  • Alginor

    Harvests and biorefines Norwegian kelp into formaldehyde-free ingredients for pharma and nutraceutical manufacturers
    Avaldsnes, NorwayBiotech & pharmaFounded 2014
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Bootstrap
  • Cloudflare
  • Google Analytics 4
  • WordPress
  • jQuery